Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

Spotlight

01.15.14 Allena Pharmaceuticals to Present at the 2014 J.P. Morgan Healthcare Conference

03.28.12 Allena Pharmaceuticals Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies